Clinical trial
The Effect of a Single Intravenous Injection of Esketamine During Cesarean Section on Postoperative Pruritus in Patients With Intrahepatic Cholestasis of Pregnancy:A Single-center Randomized Controlled Trial
NCT07560722 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of a Single Intravenous Injection of Esketamine During Cesarean Section on Postoperative Pruritus in Patients With Intrahepatic Cholestasis of Pregnancy:A Single-center Randomized Controlled Trial
- Lead sponsor
- Tianjin Medical University General Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 5, 2026
- Completion date
- August 11, 2027
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intrahepatic cholestasis of pregnancy